Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
29,684,722
-
Shares change
-
+23,428
-
Total reported value, excl. options
-
$42,741,693
-
Value change
-
-$358,246
-
Put/Call ratio
-
163%
-
Number of buys
-
18
-
Number of sells
-
19
-
Price
-
$1.44
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2021
As of 31 Dec 2021 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,684,722 shares of stock of the company.
Largest 10 holders included BVF INC/IL, NEA Management Company, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 43 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.